Ambu downgrades financial guidance

The Danish medtech firm has announced in a stock exchange notification that it is lowering its expectations for the year due to a number of current and upcoming challenges.

Photo: Ambu / PR

Ambu has downgraded its guidance for the 2021/2022 financial year, it reveals in a stock exchange notification.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs